CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 90 enrolled
Drug / intervention
Celecoxib +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03818932
NCT03818932Phase 3Completed

Traditional vs. Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

Henry Ford Health System·interventional·Posted Jan 28, 2019·Updated Mar 19, 2026

In Brief

A Phase 3 clinical trial evaluating Celecoxib, Hydrocodone-Acetaminophen, and 4 other interventions for Anterior Cruciate Ligament Injury. Completed, enrolled 90 participants across 1 site.

Detailed Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedJan 28, 2019
Enrollment StartJan 22, 2019
Primary CompletionJan 20, 2020
Study CompletionMay 20, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.4 years ago

Interventions

Celecoxibdrug

Post-Operative Non Opioid Pain Protocol

Hydrocodone-Acetaminophendrug

Traditionally used narcotic pain protocol

Ketorolacdrug

Post-Operative Non Opioid Pain Protocol

Gabapentindrug

Post-Operative Non Opioid Pain Protocol

Acetaminophendrug

Post-Operative Non Opioid Pain Protocol

Diazepamdrug

Post-Operative Non Opioid Pain Protocol